Ebrahim Alboghbaish

Mr. Ebrahim Alboghbaish

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2024 in Computers
Verified
Journal Article
Open access
PDF file
AEAlaa Eleyan
Alaa Eleyan
EAEbrahim Alboghbaish
Ebrahim Alboghbaish
Cardiovascular diseases (CVDs) like arrhythmia and heart failure remain the world’s leading cause of death. These conditions can be triggered by high blood pressure, diabetes, and simply the passage of time. The early detection of these heart issues, despite substantial advancements in artificial intelligence (AI) and technology, is still a significant challenge. This research addresses this hurdle by developing a deep-learning-based system that is capable of predicting arrhythmias and heart failure from abnormalities in electrocardiogram (ECG) signals. The system leverages a model that combines long short-term memory (LSTM) networks with convolutional neural networks (CNNs). Extensive experiments were conducted using ECG data from both the MIT-BIH and BIDMC databases under two scenarios. The first scenario employed data from five distinct ECG classes, while the second focused on classifying data from three classes. The results from both scenarios demonstrated that the proposed deep-learning-based classification approach outperformed existing methods.

29 August 2024 in Applied System Innovation
Verified
Journal Article
Open access
PDF file
AEAlaa Eleyan
Alaa Eleyan
EAEbrahim Alboghbaish
Ebrahim Alboghbaish
AAAbdulwahab Alshatti
Abdulwahab Alshatti
AAAhmad Mohammad Alsultan
Ahmad Mohammad Alsultan
DADarbi Abdulfatah Aldarbi
Darbi Abdulfatah Aldarbi
Heart disease, a global killer with many variations like arrhythmia and heart failure, remains a major health concern. Traditional risk factors include age, cholesterol, diabetes, and blood pressure. Fortunately, artificial intelligence (AI) offers a promising solution. We have harnessed the power of AI, specifically deep learning and convolutional neural networks (CNNs), to develop Rhythmi, an innovative mobile ECG diagnosis device for heart disease detection. Rhythmi leverages extensive medical data from databases like MIT-BIH and BIDMC. These data empower the training and testing of the developed deep learning model to analyze ECG signals with accuracy, precision, sensitivity, specificity, and F1-score in identifying arrhythmias and other heart conditions, with performances reaching 98.52%, 98.55%, 98.52%, 99.26%, and 98.52%, respectively. Moreover, we tested Rhythmi in real time using a mobile device with a single-lead ECG sensor. This user-friendly prototype captures the ECG signal, transmits it to Rhythmi’s dedicated website, and provides instant diagnosis and feedback on the patient’s heart health. The developed mobile ECG diagnosis device addresses the main problems of traditional ECG diagnostic devices such as accessibility, cost, mobility, complexity, and data integration. However, we believe that despite the promising results, our system will still need intensive clinical validation in the future.